| Morris County Hospital | |
|
703 Main St Alta Vista KS 66834 | |
| (620) 767-6811 | |
| (620) 767-5611 |
| Full Name | Morris County Hospital |
|---|---|
| Speciality | Clinic/Center |
| Location | 703 Main St, Alta Vista, Kansas |
| Authorized Official Name and Position | Ronald C Christenson (CFO) |
| Authorized Official Contact | 6207676811 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Morris County Hospital 600 N Washington St Council Grove KS 66846-1499 Ph: (620) 767-6811 | Morris County Hospital 703 Main St Alta Vista KS 66834 Ph: (620) 767-6811 |
| NPI Number | 1649826280 |
|---|---|
| Provider Enumeration Date | 08/09/2019 |
| Last Update Date | 08/09/2019 |
| Medicare PECOS PAC ID | 8426096504 |
|---|---|
| Medicare Enrollment ID | O20190913000841 |
News Archive
Chronically homeless, alcohol-dependent individuals might benefit from a new intervention that does not require them to stop or even reduce drinking, according to the results of a preliminary study in Seattle.
Conventional wisdom holds that the more people stay within their own social groups and avoid others, the less likely a small disease outbreak will turn into full-blown epidemic. But this conventional wisdom might be quite wrong, according to two Santa Fe Institute researchers, and the consequences could reach far beyond epidemiology.
Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced new clinical data from USpella, the first U.S. multicenter registry of Impella 2.5 patients evaluating the safety and feasibility of left ventricular support with the Impella 2.5 during high-risk percutaneous coronary intervention (PCI) and treatment of acute myocardial infarction (AMI).
Two female brain tumor patients have become the first people in the south of England to be treated using a faster form of radiotherapy that extends more advanced care to more patients. RapidArc technology from Varian Medical Systems (NYSE: VAR) makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT.
Tasmanian Devil Salem died at age seven but made a difference to her endangered species. Only 50 micrograms of her tissue was taken and processed by Australian genetic scientist Elizabeth Murchison, using new US technology, to produce the first devil genome sequence. As a result, the fight against devil facial tumor disease now has a draft DNA reference map. This was presented at a genetic conference in Hobart yesterday.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649826280 | NPI | - | NPPES |
| PENDING | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QR1300X | Clinic/center - Rural Health | (* (Not Available)) | Primary |
News Archive
Chronically homeless, alcohol-dependent individuals might benefit from a new intervention that does not require them to stop or even reduce drinking, according to the results of a preliminary study in Seattle.
Conventional wisdom holds that the more people stay within their own social groups and avoid others, the less likely a small disease outbreak will turn into full-blown epidemic. But this conventional wisdom might be quite wrong, according to two Santa Fe Institute researchers, and the consequences could reach far beyond epidemiology.
Abiomed Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today announced new clinical data from USpella, the first U.S. multicenter registry of Impella 2.5 patients evaluating the safety and feasibility of left ventricular support with the Impella 2.5 during high-risk percutaneous coronary intervention (PCI) and treatment of acute myocardial infarction (AMI).
Two female brain tumor patients have become the first people in the south of England to be treated using a faster form of radiotherapy that extends more advanced care to more patients. RapidArc technology from Varian Medical Systems (NYSE: VAR) makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT.
Tasmanian Devil Salem died at age seven but made a difference to her endangered species. Only 50 micrograms of her tissue was taken and processed by Australian genetic scientist Elizabeth Murchison, using new US technology, to produce the first devil genome sequence. As a result, the fight against devil facial tumor disease now has a draft DNA reference map. This was presented at a genetic conference in Hobart yesterday.
› Verified 7 days ago